Who mentions $AVXL most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $AVXL most — 16 mentions in the past 12 months.

When was $AVXL first mentioned on Surfaced?

The earliest tracked mention of $AVXL in the Surfaced archive was on Sep 9, 2025.

How many voices track $AVXL?

1 FinTwit voice has mentioned $AVXL 16 times in the past 12 months.

What kind of voices mention $AVXL most?

$AVXL is mentioned most by Biotech voices on Surfaced.

$AVXL — FinTwit mentions on Surfaced

Recent mentions

16 mentions

@adamfeuersteinMay 6, 2026 · 1:03 PM

$AVXL CEO Chris Missling - fired. The 8K spells it out. Terminated for cause. https://t.co/HzBCPfX0gV One of biotech's worst peddlers of bullshit is gone. I might actually miss him. https://t.co/ZbDslD7jGj

Open on X

@adamfeuersteinMay 6, 2026 · 11:30 AM

$AVXL - CEO Chris Missling is out. The board asked for his resignation. https://t.co/sU1FgH5mdE

Open on X

@adamfeuersteinMar 25, 2026 · 11:36 AM

$AVXL pulled its blarcamesine Alzheimer's application from the EMA after regulators there said there was no fking way it was going to approve a drug that does not work. <sad trombone>

Open on X

@adamfeuersteinDec 12, 2025 · 2:01 PM

$AVXL blarcarmesine formally rejected by EMA's CHMP advisers. The review is brutal: https://t.co/jMP61Cmplk https://t.co/S8UgDKktCE

Open on X

@adamfeuersteinNov 14, 2025 · 1:13 PM

When $AVXL finally ends, CEO Chris Missling should put together an exhibition of the AI-generated "art" he inserts into the company's press releases. We could all attend the show and drink bad red wine together. https://t.co/V0rE98mOtd

Open on X

@adamfeuersteinNov 14, 2025 · 12:34 PM

$AVXL news, after all! CHMP negative trend vote. Goodbye! https://t.co/RmhXVsTYQK

Open on X

@adamfeuersteinNov 14, 2025 · 11:25 AM

$AVXL - No CHMP recommendation this month, wait for December. https://t.co/FNJDcnd8jt

Open on X

@adamfeuersteinNov 13, 2025 · 7:06 PM

@Sanctuary_Bio My first $AVXL (skeptical/negative, of course) was Nov. 2015. The effort to promote Anavex Life Sciences with claims of a cure for Alzheimer’s disease began this summer and intensified more recently as the company underwent a reverse stock split and moved from trading on the bulletin boards to the Nasdaq...

Open on X

@adamfeuersteinNov 13, 2025 · 5:19 PM

You're welcome, @MartinShkreli. I'm always happy to help you. $AVXL

Open on X

@adamfeuersteinNov 10, 2025 · 1:44 PM

$AVXL blarcamesine is on the CHMP agenda this week. Oral explanation hearing tomorrow. https://t.co/bqVqEYlxHo

Open on X

@adamfeuersteinOct 29, 2025 · 11:43 AM

$AVXL in full panic mode. With EMA rejection of blarcamesine looming, the company must be trying to sell as much stock as it can with the $150M ATM in place. That explains this morning's 🙄press release.

Open on X

@adamfeuersteinOct 23, 2025 · 12:42 PM

Time is running out for Anavex $AVXL and its treatment for Alzheimer’s disease. EMA rejection is coming. https://t.co/Q0BxxmB7s0

Open on X

@adamfeuersteinOct 13, 2025 · 12:17 PM

@jackbsadler $AVXL Likely too early, yes. “No withdrawal” is not positive news, also just too early. Either a rejection or withdrawal is coming 99.9999%, just a matter of when.

Open on X

@adamfeuersteinOct 13, 2025 · 11:52 AM

$AVXL not on the October EMA CHMP agenda.

Open on X

@adamfeuersteinSep 10, 2025 · 1:14 PM

@Biotenic $AVXL is in a bind bc EMA CHMP opinions are published. Timing is likely end of year, beginning of '26, depending on when the drug hits the CHMP agenda. Missling could withdraw the application and spin it, make some excuse. He's in a tough spot. Rejection is inevitable, it's just a matter of time and how it plays out. Re: $NWBO - MHRA isn't as transparent as EMA, which is how mgmt has been able to delay/distract/avoid disclosing the DCVax-L rejection. NWBO has a long history of not disclosing material events, dating back to 2015 and the ph3 futility finding that showed DCVax caused harm and put the study on FDA hold. For awhile, NWBO was hiding behind the MHRA drug review backlog, but that's been cleared so it's no longer an excuse. As you noted, the DCVax application has been in front of MHRA since Dec. 2023 -- an unbelievable 21 months! The drug was rejected. When or even if NWBO ever acknowledges, who knows? If history is a guide, maybe never. The company will continue to limp along, raising debt and selling shares each month to keep the lights on. NWBO has not treated a single patient with DCVax in a clinical trial for 10 years.

Open on X

@adamfeuersteinSep 9, 2025 · 11:40 AM

Every time you see another $AVXL press release touting some arcane analysis of blarcamesine in Alzheimer's disease, please remember: The drug failed, it does nothing, and CEO Chris Missling doesn't want to admit that European regulators are rejecting it.

Open on X

Frequently asked